» Articles » PMID: 36372842

Prognostic Factors and Outcomes of Surgical Intervention for Patients with Spinal Metastases Secondary to Lung Cancer: an Update Systematic Review and Meta Analysis

Overview
Journal Eur Spine J
Specialty Orthopedics
Date 2022 Nov 13
PMID 36372842
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lung cancer is one of the most common malignant tumors. Most patients develop spinal metastases during the course of cancer and suffer skeletal-related events. Currently, no consensus has been reached on the prognostic factors in patients undergoing surgeries. This study aimed to answer two questions: (1) what are the effects of surgical intervention, and (2) what are the factors associated with postoperative survival.

Methods: Searches were performed on electronic databases including PubMed, Ovid/MEDLINE, Cochrane, and Scopus for articles published before February of 2022, involving the survival factors of patients with spinal metastasis. Multiple data items were considered, such as baseline demographics, surgical details, clinical outcome, and prognostic factors. The analysis was performed in Review Manager (RevMan) 5.5. The prognostic factors of survival were analyzed with univariate and multivariate cox regression analysis.

Results: Finally, 14 studies with 813 patients were identified. Their 6, 12, and 24 months survival rates ranged from 18 to 58%, 18 to 22.4%, and 0 to 58.5%, respectively. The pooled hazard ratio of preoperative ambulatory status and the number of involved vertebrae demonstrated statistical significance, while no significant prognostic effect on the overall survival was found for targeted therapy, visceral metastases, chemotherapy, radiotherapy, or postoperative ambulatory status.

Conclusion: Overall, surgical intervention could achieve significant pain relief and neurological function improvements. For patients receiving surgery for spinal metastasis from lung cancer, preoperative ambulatory status and the number of involved vertebrae were significant prognostic factors associated with their survival.

Citing Articles

Construction and Development of an Enhanced Recovery After Surgery Program for the Surgical Management of Patients With Spinal Metastasis: A Modified Delphi Study.

Li F, Yu W, Zhou H, Zhang F, Zhou Z, Gao Q Orthop Surg. 2025; 17(3):939-952.

PMID: 39846269 PMC: 11872384. DOI: 10.1111/os.14375.


New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies.

Xue M, Ma L, Zhang P, Yang H, Wang Z Int J Biol Sci. 2024; 20(14):5747-5763.

PMID: 39494330 PMC: 11528464. DOI: 10.7150/ijbs.100960.


Development of a core outcome set of clinical research on the integration of traditional Chinese and Western medicine for spinal metastases: .

Fang G, Yu W, Chen D, Ding X, Qiao L, Zhang L BMJ Open. 2024; 14(9):e083315.

PMID: 39260838 PMC: 11409365. DOI: 10.1136/bmjopen-2023-083315.


Assessment of survival prediction after surgery in spinal metastases patients using the Global Spine Study Tumor Group (GSTSG) risk calculator; an external validation from a tertiary cancer hospital.

Trathitephun W, Arunwatthanangkul P, Pakmanee N, Kamolpak J, Wanitchakorn S, Pichyangkul M Eur Spine J. 2024; 33(11):4336-4345.

PMID: 39103613 DOI: 10.1007/s00586-024-08439-8.


Effect of radiotherapy on local control and overall survival in spinal metastasis of non-small-cell lung cancer after surgery and systemic therapy.

Wang S, Chen Z, Wang K, Li H, Qu H, Mou H Bone Jt Open. 2024; 5(4):350-360.

PMID: 38649150 PMC: 11035006. DOI: 10.1302/2633-1462.54.BJO-2024-0037.R1.

References
1.
Hsieh M, Bowles D, Canseco J, Sherman M, Schroeder G, Vaccaro A . Is Open Surgery for Metastatic Spinal Cord Compression Secondary to Lung Cancer Really Beneficial? A Systematic Review. World Neurosurg. 2020; 144:e253-e263. DOI: 10.1016/j.wneu.2020.08.098. View

2.
da Silva G, Bergmann A, Thuler L . Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer: a systematic review of the literature. Eur Spine J. 2015; 24(10):2107-13. DOI: 10.1007/s00586-015-4157-x. View

3.
Xiong G, Fisher M, Schwab J, Simpson A, Nguyen L, Tobert D . A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes. Spine (Phila Pa 1976). 2022; 47(7):515-522. PMC: 8923973. DOI: 10.1097/BRS.0000000000004322. View

4.
Tan J, Tan K, Zaw A, Thomas A, Hey H, Soo R . Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer. Spine (Phila Pa 1976). 2016; 41(7):638-44. DOI: 10.1097/BRS.0000000000001279. View

5.
Uei H, Tokuhashi Y . Prognostic factors in patients with metastatic spine tumors derived from lung cancer-a novel scoring system for predicting life expectancy. World J Surg Oncol. 2018; 16(1):131. PMC: 6034326. DOI: 10.1186/s12957-018-1439-x. View